arker's Market, Revenue ($bn), 2004–2011 19Table 4: Biomarkers in Drug Discovery, Global Biomarker's Market, Revenue Forecast ($bn), 2011–2018 19Table 5: Biomarkers in Drug Discovery, Global, Biomarker Discovery by Mass Spectrometry, Problems and Solutions, 2012 33Table 6: Biomarkers in Drug Discovery, Global, Examples of Biomarkers, 2012 47Table 7: Biomarkers in Drug Discovery, Global, Herceptin Development Timeline, 2012 55Table 8: Biomarkers in Drug Discovery, Global, Validated Biomarkers Applied in FDA-approved Drugs, 2012 62Table 9: Biomarkers in Drug Discovery, Global, Imaging and Cerebrospinal Fluid Biomarker Categories in Alzheimer's Disease, 2012 66Table 10: Biomarkers in Drug Discovery, Global, Prognostic and Diagnostic Biomarkers for Cancer, 2012 68Table 11: Biomarkers in Drug Discovery, Global, Micro RNAs as Biomarkers of Cancer, 2012 69Table 12: Biomarkers in Drug Discovery, Global, Cerebrospinal Fluid Biomarkers in Multiple Sclerosis, 2012 70Table 13: Biomarkers in Drug Discovery, Global, Micro RNA as Biomarker for Rheumatoid Arthritis, 2012 71Table 14: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Mergers and Acquisitions, 2011–2012 75Table 15: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Licensing Agreement Deals, 2011–2012 77Table 16: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Partnerships Deals, 2011–2012 79`
1.2 List of Figures
Figure 1: Biomarkers in Drug Discovery, Global, Commonly Identified Biomarkers, 2012 10Figure 2: Biomarkers in Drug Discovery, Global, History of Biomarkers, 2012 11Figure 3: Biomarkers in Drug Discovery, Global, Biomarkers Cater to the Unmet Needs of Conventional Drug Discovery Methods, 2012 13Figure 4: Biomarkers in Drug Discovery, Global, Reasons for Attrition, 2012 14Figure 5: Biomarkers in Drug Discovery, Global, Biomarker Discovery and Validation Process, 2012 16Figure 6: Biomarkers in Drug Discovery, Global Biomarke
'/>"/>
SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine technology :1.
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles2.
Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy3.
Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria4.
Discovery Labs Appoints John R. Leone to Board of Directors5.
Aptuit Drug Discovery & Development Center In Verona, Italy Hits 100th Client Milestone6.
Del Mar CEO Delivers Keynote Address at International Drug Discovery Science and Technology Conference7.
Discovery Labs Reports Third Quarter 2012 Financial Results8.
BD Completes Sale of Majority of Discovery Labware Unit9.
Discovery of New "Youth Pill" Revealed At International Scientific Conference10.
Drug Discovery in Rare Diseases11.
ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)